Author

Chengzi I. Kaku

Scripps Research InstituteORCID 0000-0002-9854-8351Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Daniel W. MielcarziD· 1 shared Garrett Rappazzo· 1 shared Jiwon LeeiD· 1 shared Jordan Wentworth· 1 shared Joshua A. WeineriD· 1 shared Laura M. WalkeriD· 1 shared Margaret E. AckermaniD· 1 shared Mrunal SakharkariD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Daniel W. MielcarzORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyPathogens and ImmunityPeer-reviewedJun 18, 2024

Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2

Ruth I. Connor, Mrunal Sakharkar, Garrett Rappazzo…·Peter F. Wright

This study identifies infection-enhancing antibodies targeting the N-terminal domain of SARS-CoV-2 spike protein, which persist in convalescent patients and may be counteracted by viral mutations.

8 citations

humanproteomics

𝕏 PostBluesky